🇺🇸 FDA
Pipeline program

Rosuvastatin (5mg,10mg,20mg)

CJFH-20150203-CAP

Approved small_molecule active

Quick answer

Rosuvastatin (5mg,10mg,20mg) for Carotid Atherosclerosis is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Carotid Atherosclerosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials